학술논문
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
Document Type
Artikel
Author
Source
Molecular oncology. 16(12):2312-2329
Subject
Language
English
English
English
ISSN
1878-0261